What InspireMD Inc's executives and directors are doing with their own shares, from SEC Form 3/4/5 filings — separating what the filings state (awards, withholding, disclosed plans) from what only the pattern of dates shows.
| 3 months | 12 months | |
|---|---|---|
| Open-market buys | 0 | 15 |
| Sells | 0 | 12 |
| Total trades | 0 | 38 |
| 3 months | 12 months | |
|---|---|---|
| Acquired | 0 | 1,796,746 |
| Disposed | 0 | 86,913 |
| Net activity | +0 | +1,709,833 |
Common stock only — 1 reported trade in the last 12 months is in a security these totals do not cover.
View rich charts and dive into the patterns of specific insiders — who is accumulating, who is winding down, and which sale explanations the filings actually support.
| Insider | Relation | Date | Transaction | Shares | Price | Value | Shares held |
|---|---|---|---|---|---|---|---|
| Stuka Paul | Director | May 27 | Open-market buy · P | +20,000 | $0.88 | +$17.5K | 667,871 |
| Gleason Shane Thomas | Chief Commercial Officer | May 19 | Sale for tax withholding · S | −22,778 | $1.01 | −$23K | 1,053,882 |
| Stuka Paul | Director | May 14 | Open-market buy · P | +5,000 | $1.15 | +$5.75K | 647,871 |
| Stuka Paul | Director | May 13 | Open-market buy · P | +10,000 | $1.16 | +$11.6K | 642,871 |
| Slosman Marvin | CEO and President | May 12 | Open-market buy · P | +21,000 | $1.20 | +$25.2K | 3,556,658 |
| Stuka Paul | Director | May 11 | Open-market buy · P | +10,000 | $1.19 | +$11.9K | 632,871 |
| Stuka Paul | Director | May 08 | Open-market buy · P | +65,626 | $1.16 | +$76.1K | 622,871 |
| Roubin Gary S | Director | May 07 | Open-market buy · P | +90,000 | $1.18 | +$106K | 834,478 |
| Stuka Paul | Director | May 07 | Open-market buy · P | +6,378 | $1.15 | +$7.33K | 531,599 |
| Ward Scott R | Director | May 07 | Open-market buy · P | +73,255 | $1.15 | +$84.2K | 237,096 |
| Stuka Paul | Director | May 06 | Open-market buy · P | +1,517 | $1.12 | +$1.7K | 525,221 |
| Ward Scott R | Director | May 06 | Open-market buy · P | +15,995 | $1.15 | +$18.4K | 163,841 |
| Gleason Shane Thomas | Chief Commercial Officer | Feb 02 | Sale for tax withholding · S | −2,941 | $1.59 | −$4.68K | 1,076,660 |
| Gleason Shane Thomas | Chief Commercial Officer | Feb 02 | Sale for tax withholding · S | −2,000 | $1.60 | −$3.21K | 1,139,177 |
| Gleason Shane Thomas | Chief Commercial Officer | Jan 30 | Sale for tax withholding · S | −2,900 | $1.63 | −$4.73K | 1,141,177 |
| Gleason Shane Thomas | Chief Commercial Officer | Jan 29 | Sale for tax withholding · S | −5,000 | $1.65 | −$8.25K | 1,144,077 |
| Gleason Shane Thomas | Chief Commercial Officer | Jan 28 | Sale for tax withholding · S | −12,395 | $1.65 | −$20.5K | 1,149,077 |
| Gleason Shane Thomas | Chief Commercial Officer | Jan 27 | Sale for tax withholding · S | −4,781 | $1.66 | −$7.96K | 1,161,472 |
| Gleason Shane Thomas | Chief Commercial Officer | Jan 22 | Sale for tax withholding · S | −8,411 | $1.57 | −$13.2K | 1,166,253 |
| Gleason Shane Thomas | Chief Commercial Officer | Jan 21 | Sale for tax withholding · S | −17,593 | $1.62 | −$28.6K | 1,174,664 |
Loading...
